BIOLOGICAL · Unmapped registry intervention
allogeneic tumor cell vaccine
Find medicine records ·
Find other trials using this name
Clinical trial
Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer
NCT00814892
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
therapeutic autologous dendritic cells
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedVaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
allogeneic tumor cell vaccineBIOLOGICAL
therapeutic autologous dendritic cellsBIOLOGICAL
Sponsors & collaborators
Mayo Cliniclead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00814892 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.